Mining the genome for medicine
00
Days
:
00
Hrs
:
00
Min
:
00
Sec
Genome San Diego 2018 invites participants from all over the world to attend The "2nd International Conference and Exhibition on Genome Science" during Nov 26-28, 2018 in San Diego, USA.
We cordially invite all the participants who are interested in sharing their knowledge and research in the area of Genome Science. Genome conference will bring together specialists working on the interface between genome sciences. Our conference will cover the most recent and exciting advances in genome research. The genome conference invites research scientists, professors, students, councilors, exhibitors, academicians, entrepreneurs, lab technicians, technology developers, policymakers and other genetic professionals to learn about new discoveries and discuss their own conclusion in their research. As the foundation of life, genetics provides a base for other sciences to grow from. As we learn more about genetics and genomics applications, further knowledge can be integrated into diagnosis and treatment of disease and learning more about the complexities of human biology.
|
|
Monday, November 26th, 2018 |
|
08:30 am – 09:00 am |
Registration Desk Opens |
|
09:00 am – 10:00 am |
Welcome Message |
|
10:00 am – 10:30 pm |
Networking Coffee Break & Exhibition Visit |
|
10:30 am – 12:30 pm |
Scientific Session 1 |
|
12:30 pm – 01:30 pm |
Networking Lunch & Exhibition Visit |
|
01:30 pm – 03:30 pm |
Poster Session 1 |
|
03:30 pm – 04:00 pm |
Networking Coffee Break & Exhibition Visit |
|
04:00 pm – 06:00 pm |
Scientific Session 2 |
|
|
Tuesday, November 27th, 2018 |
|
09:00 am – 10:30 am |
Scientific Session 3 |
|
10:30 am – 11:00 am |
Networking Coffee Break & Exhibition visit |
|
11:00 am – 12:30 pm |
Poster Session 2 |
|
12:30 am – 01:30 pm |
Networking Lunch & Exhibition Visit |
|
01:30 pm – 03:00 pm |
E – poster presentation 1 |
|
03:00 pm – 03:30 pm |
Networking Coffee Break & Exhibition visit |
|
03:30 pm – 06:00 pm |
Scientific Session 4 |
|
|
Wednesday, November 28th, 2018 |
|
09:00 am – 10:30 am |
Scientific Session 5 |
|
10:30 am – 11:00 am |
Networking Coffee Break & Exhibition visit |
|
11:00 am – 12:30 pm |
Poster Session 3 |
|
12:30 am – 01:30 pm |
Networking Lunch & Exhibition Visit |
|
01:30 pm – 03:00 pm |
Scientific Session 6 |
|
03:00 pm – 03:30 pm |
Networking Coffee Break & Exhibition visit |
|
03:30 pm – 06:00 pm |
Scientific Session 7 |
|
Award ceremony |
|
|
Conference Concludes |
|
|
(a) |
Computational genomics and proteomics |
|
(b) |
Tools for functional and comparative genomics |
|
(c) |
Genome sequencing and assembly |
|
(d) |
Bio data mining and Data integration methods |
|
(e) |
Cloud and workflow platforms for bioinformatics |
|
(f) |
Genome analysis and Phylogeny |
|
(g) |
Exploratory analysis of biological data using R |
|
(h) |
Bioinformatics for cancer genomics |
|
(i) |
Genomics organism model |
|
(j) |
Technology advancement |
|
(k) |
System biology and genetics |
|
(l) |
Molecular modeling and drug designing |
|
(m) |
Other |
|
(a) |
Cancer genome analysis, sequencing, and alignment |
|
(b) |
Systems Biology & Systems Pharmacology |
|
(c) |
genome-wide association studies and Cell fate in cancer |
|
(d) |
Personal genome screening |
|
(e) |
Sequencing mutations or somatic cancer genetic studies |
|
(f) |
Epigenetic changes in cancer and Cancer epidemiology |
|
(g) |
Cancer Nanotheranostics, genome therapy, and Biopsy |
|
(h) |
Cancer Model Systems & Integrated Analyses of Cancer |
|
(i) |
Translation & Clinical Impact of Cancer Genomics |
|
(j) |
Tumor Hetero genetics |
|
(k) |
Cancer Metabolism |
| (l) | Other |
Submit Your Abstract Suggest Your session Edit Description
|
(a) |
Plant taxonomy and ecology |
|
(b) |
Plant pathology and physiology |
|
(c) |
Plant breeding and crop breeding |
|
(d) |
Transgenic Plants |
|
(e) |
Plant Epigenetics and plant science |
|
(f) |
Crop protection and management |
|
(g) |
Weed Science and rice genome |
|
(h) |
Tissue culture and plant biotechnology |
|
(i) |
Breeding Genomics |
|
(j) |
Plant Physiology |
|
(k) |
other |
|
(a) |
Human genome engineering |
|
(b) |
Multiplex Automated Genomic Engineering |
|
(c) |
Genome Profiling |
|
(d) |
CRISPR/CAS Revolution in Genome Engineering |
|
(e) |
Induced Pluripotent Stem Cell Technology |
|
(f) |
Targeted Genome Editing |
|
(g) |
Plant Genome Engineering and Genome Reprogramming |
|
(h) |
Advances in Genome Editing |
|
(i) |
Other |
|
(a) |
Data sharing and privacy issues |
|
(b) |
Informed consent |
|
(c) |
Policy, legal and regulatory issues |
|
(d) |
Return of genetic test results |
|
(e) |
Social and cultural implications of genetic and genomic technologies |
|
(f) |
Other |
|
(a) |
Transcription regulation |
|
(b) |
Genomic Sequencing |
|
(c) |
Posttranscriptional regulation/RNA editing |
|
(d) |
Functional genomics and bioinformatics |
|
(e) |
Genomic responses in differentiation, disease, stress or stimulation |
|
(f) |
Chromatin characteristics/nuclear organization |
|
(g) |
Copy number variation |
|
(h) |
Chromatin & Epigenetics |
|
(i) |
Microbiomes |
|
(j) |
Other |
|
|
|
(a) |
Genetic counseling |
|
(b) |
Molecular pharming |
|
(c) |
Genetic epidemiology and pharmacoepidemiology |
|
(d) |
Synthetic biology and bioengineering |
|
(e) |
Translational genetics and genomics |
|
(f) |
Phenomics |
|
(g) |
Other |
|
(a) |
Chromosomal disorders and gene therapy for cancer treatment |
|
(b) |
Clinical gene therapy and genomics healthcare |
|
(c) |
Laboratory experiences regarding genetic, genomic testing and screening |
|
(d) |
Molecular genetics of complex diseases |
|
(e) |
Tools and techniques in clinical genetics |
|
(f) |
Other |
|
|
(a) |
Clinical Epigenetics |
|
(b) |
X-inactivation |
|
(c) |
Histone modification |
|
(d) |
Twin studies |
|
(e) |
Imprinting |
|
(f) |
DNA methylation |
|
(g) |
Other |
|
(a) |
Genome-wide association studies |
|
(b) |
Development |
|
(c) |
Tandem repeats, triplet expansions, and disease |
|
(d) |
Diagnostic methods |
|
(e) |
Functional studies of associated variants or loci |
|
(f) |
Gene-environment interactions |
|
(g) |
Neuroimaging genetics |
|
(h) |
Predictors of progression and response to treatment |
|
(i) |
Other |
|
(a) |
Annotated sequences of cattle |
|
(b) |
Regulation of genes in livestock |
|
(c) |
Microbial genetics |
|
(d) |
Ecoli Genome and Genomics |
|
(e) |
Bacterial and viral Genomic |
|
(f) |
Buffalo and poultry genomes |
|
(h) |
Other |
|
(a) |
Cancer evolutionary genomics |
|
(b) |
Gene cluster and Gene Rearrangement |
|
(c) |
Genomic Variation |
|
(d) |
Gene Order and Phylogenetic reconstruction |
|
(e) |
Algorithms for genome evolution |
|
(f) |
Comparative tools for genome assembly |
|
(g) |
Other |
|
(a) |
Human genome engineering |
|
(b) |
Multiplex Automated Genomic Engineering |
|
(c) |
Genome Profiling |
|
(d) |
CRISPR/CAS Revolution in Genome Engineering |
|
(e) |
Induced Pluripotent Stem Cell Technology |
|
(f) |
Targeted Genome Editing |
|
(g) |
Plant Genome Engineering and Genome Reprogramming |
|
(h) |
Advances in Genome Editing |
|
(i) |
Other |
|
(a) |
Biological and small molecule therapeutics |
|
(b) |
Functional studies of associated variants or loci |
|
(c) |
Genome-wide association studies |
|
(d) |
Pharmacogenitics & Individualized therapy |
|
(e) |
Pharmacodynamics |
|
(f) |
Nutrigenomics and Toxicogenomics |
|
(g) |
Sequencing studies/rare variants |
|
(h) |
Biomarker translation and testing |
|
(i) |
Small molecule screening and in vitro |
|
(j) |
Other |
|
|
(a) |
Statistical analysis programs/software |
|
(b) |
Analysis of risk, genotype or phenotype, penetrance and individual variants association methods |
|
(c) |
Study Design, Quality control, Pre-Processing, Population Stratification adjustments |
|
(d) |
Family-based association, identity-by-descent, linkage or segregation methods |
|
(e) |
Pathway, network, Systems Analysis, Gene x Gene and Gene x Environment Analysis |
|
(f) |
Other |
